Overview
KPV is the C-terminal tripeptide sequence of alpha-melanocyte-stimulating hormone, composed of lysine-proline-valine. It is most commonly discussed in anti-inflammatory, barrier-tissue, gut, skin, and immune-response research.
KPV is important because many anti-inflammatory effects attributed to alpha-MSH-related peptides have been linked to this short terminal sequence. That makes KPV a compact research peptide with a surprisingly broad literature footprint.
KPV should be presented as an inflammation and barrier-function research peptide. It is related to alpha-MSH biology and melanocortin research, but the clearest scientific framing focuses on immune modulation, epithelial tissues, and inflammation models rather than broad wellness claims.